Issued Patents 2021
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date | Approx Value ⓘ |
|---|---|---|---|---|
| 11161838 | Heterocyclic derivatives as PI3K inhibitors | Yanran Ai, Andrew P. Combs, Artem Shvartsbart | 2021-11-02 | $33,545,000 |
| 11091484 | Tricyclic heterocycles as BET protein inhibitors | James D. Rodgers, Haisheng Wang, Lixin Shao | 2021-08-17 | $40,819,000 |
| 11091491 | Heterocyclic compounds as PI3K-y inhibitors | Artem Shvartsbart, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh, Ge Zou +4 more | 2021-08-17 | $40,819,000 |
| 11078204 | Heterocyclic derivatives as PI3K inhibitors | Yanran Ai, Andrew P. Combs, Nikoo Falahatpisheh, Lixin Shao, Artem Shvartsbart | 2021-08-03 | $119,046,000 |
| 11046658 | Aminopyrazine derivatives as PI3K-γ inhibitors | Brent Douty, Yanran Ai, David M. Burns, Andrew P. Combs, Nikoo Falahatpisheh +6 more | 2021-06-29 | $68,992,000 |
| 10975088 | Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors | Andrew W. Buesking, Richard B. Sparks, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh +5 more | 2021-04-13 | $77,418,000 |